Reversal of 'atypical'-multidrug resistance by recombinant human tumor necrosis factor in the human ovarian cancer cell line A2780-DX3

MLA

Cimoli, G., et al. Reversal of ’Atypical’-Multidrug Resistance by Recombinant Human Tumor Necrosis Factor in the Human Ovarian Cancer Cell Line A2780-DX3. Jan. 1993. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....30fff690bbc486c8a5030d18d88ef531&authtype=sso&custid=ns315887.

APA

Cimoli, G., Valenti, M., Parodi, S., Mazzoni, A., Sessa, F., Conte, P., & patrizia russo. (1993). Reversal of ’atypical’-multidrug resistance by recombinant human tumor necrosis factor in the human ovarian cancer cell line A2780-DX3.

Chicago

Cimoli, G., M. Valenti, S. Parodi, A. Mazzoni, F. Sessa, P. Conte, and patrizia russo. 1993. “Reversal of ’Atypical’-Multidrug Resistance by Recombinant Human Tumor Necrosis Factor in the Human Ovarian Cancer Cell Line A2780-DX3,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....30fff690bbc486c8a5030d18d88ef531&authtype=sso&custid=ns315887.